This is a ready-to-use trending register for the function-level view of a validation program, the handful of numbers that tell a leader whether the program is under control before an inspector counts them instead. It does not replace any individual validation record; it aggregates the population of open and closed work over a period. Replace every <<FILL: ...>> placeholder with your own specifics. A worked filled specimen follows the template. Verify each cited regulation against the current source before you rely on it.
Document control header
| Field | Entry |
|---|---|
| Document title | Validation Program Metrics and Backlog Tracking Register |
| Document number | <<FILL: LOG-ID, e.g. LOG-VAL-006>> |
| Version | <<FILL: version, e.g. 1.0>> |
| Effective date | <<FILL: effective date>> |
| Document owner | <<FILL: role, e.g. Head of Validation>> |
| Applies to | <<FILL: sites / systems in scope>> |
| Review cadence | <<FILL: e.g. monthly, quarterly for a stable program>> |
Purpose
A validation package can be individually correct and the program around it can still be sliding out of control, a backlog that only grows, periodic reviews that quietly go overdue, deviations that stay open past their target, protocols stuck waiting for approval. Each of those is invisible in any single validation record, and each is exactly what a leader is accountable for catching before it becomes a batch of overdue systems discovered during inspection preparation.
Why track it here instead of trusting each project team to flag their own trouble? Because the pattern across projects is usually the real story, one reviewer quietly covering two roles, one approval step that has become the bottleneck for everyone, and no single project owner is positioned to see that. This register is where the trend is watched on purpose, on a schedule, instead of being noticed by accident.
How to use this register
- At the end of each review period, pull the figures from the validation inventory, the change control system, and the QMS deviation register.
- Complete one row per period in the trend table (section 1). Carry the prior period’s figures forward so the direction is visible, not just the latest snapshot.
- Compare each metric against its threshold. Where a threshold is breached, complete an escalation entry (section 3).
- Quality Assurance reviews and signs the completed period.
- Feed the period’s summary into management review per
<<FILL: management review SOP-ID>>.
1. Trend table
| Period | Open validation backlog (count) | Backlog items over <<FILL: e.g. 90>> days | Overdue periodic reviews | Open validation deviations | Open deviations over <<FILL: e.g. 30>> days | On-time protocol approval rate (%) | Requalifications due in next 90 days | Audit-trail review completion rate (%) | Validation staff training current (%) |
|---|---|---|---|---|---|---|---|---|---|
<<FILL: e.g. 2026-Q3>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
2. Thresholds and escalation
Set your own thresholds from historical baseline and risk tolerance, not a number borrowed from elsewhere. A single breach is a flag; two consecutive periods is an escalation.
| Metric | Default threshold | Action on breach |
|---|---|---|
| Open validation backlog | <<FILL: e.g. no net growth over two consecutive periods>> | Review by system risk tier; confirm high-risk items are not queued behind low-risk ones; escalate resourcing if the queue is genuinely under-resourced rather than mis-prioritized |
| Backlog items over the age threshold | <<FILL: e.g. no more than 10% of the backlog>> | Identify the specific blocker per aged item (resourcing, a stuck approval, an open deviation); do not let an aged item sit unexplained |
| Overdue periodic reviews | <<FILL: e.g. zero tolerance for high-risk systems>> | Escalate the specific systems by name and owner; a growing count on high-risk systems is treated as a state-of-control concern, not a scheduling inconvenience |
| Open validation deviations over the age threshold | <<FILL: e.g. no more than 5% open past target>> | Review each for a stated risk position and target date; a deviation with neither is escalated regardless of its classification |
| On-time protocol approval rate | <<FILL: e.g. at least 90%>> | Identify where in the approval chain delay concentrates; a single chronic bottleneck role is a process fix, not an individual reminder |
| Requalifications due in the next 90 days | Informational; not a threshold breach by itself | Confirm each has a scheduled activity and an assigned owner before it becomes overdue |
| Audit-trail review completion rate | <<FILL: e.g. 100% for high-criticality systems>> | Escalate by system; a system with no completed review has no evidence its data can be trusted, independent of its validation status |
3. Escalation log
Complete an entry whenever a threshold is breached per section 2.
| Ref | Period | Metric breached | Value vs threshold | Root cause (if known) | Action | Owner | Due date | Status |
|---|---|---|---|---|---|---|---|---|
<<FILL: ESC-1>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
4. Acceptance criteria
A period’s tracking is complete and acceptable when all of the following hold:
- Every metric in section 1 is pulled from the source system for that period, not estimated from memory.
- Every threshold breach in section 2 has a corresponding, dated escalation entry in section 3.
- Escalations from the prior period are either closed with evidence or carried forward with a current status, never silently dropped between periods.
- The period summary was reviewed and signed by QA and fed to management review within
<<FILL: number>>days of period close.
References
21 CFR 211.100 (written procedures) and 21 CFR 211.192 (review of production records). EU GMP Annex 15 (Qualification and Validation), 2015 revision. ICH Q10, Pharmaceutical Quality System, for management review and continual improvement of the quality system. ICH Q9, Quality Risk Management, for risk-based thresholds. FDA, Process Validation: General Principles and Practices (2011), for continued process verification as an ongoing program obligation.
Confirm the current version and clause numbers of each reference before issue.
5. Revision history
| Version | Date | Author | Summary of change |
|---|---|---|---|
<<FILL: 1.0>> | <<FILL: date>> | <<FILL: author>> | Initial issue. |
6. Approvals
| Role | Name | Signature | Date |
|---|---|---|---|
| Author | <<FILL>> | ||
| Reviewer (Validation Process Owner) | <<FILL>> | ||
| Approver (QA) | <<FILL>> |
Filled specimen
Illustrative two-quarter trend for a mid-size site. Replace with your own.
| Period | Open backlog | Backlog over 90 days | Overdue periodic reviews | Open deviations | Open deviations over 30 days | On-time approval rate (%) | Requalifications due next 90 days | Audit-trail review completion (%) | Training current (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q2 | 22 | 3 | 1 | 9 | 2 | 88 | 4 | 97 | 96 |
| 2026-Q3 | 31 | 7 | 3 | 14 | 6 | 79 | 6 | 91 | 94 |
Escalation log:
| Ref | Period | Metric breached | Value vs threshold | Root cause (if known) | Action | Owner | Due date | Status |
|---|---|---|---|---|---|---|---|---|
| ESC-2026-021 | 2026-Q3 | Overdue periodic reviews | 3 vs zero-tolerance threshold for high-risk systems | Two of the three are the same reviewer’s assigned systems; the reviewer covered an open validation lead vacancy for six weeks and periodic review slipped behind protocol work | Reassign the two oldest overdue reviews to a second reviewer this period; raise the vacancy coverage gap to resourcing planning | Head of Validation | 15 Oct 2026 | Open |
| ESC-2026-022 | 2026-Q3 | On-time protocol approval rate | 79% vs 90% threshold | QA approval step is the concentration point; average QA turnaround rose from 3 to 9 days after a second signer left the team | Add a temporary second QA approver for validation protocols; track turnaround weekly until back under target | QA Manager | 31 Oct 2026 | Open |
Quality Assurance review: R. Gomez, 8 October 2026. Both breaches trace to the same underlying cause, a staffing gap in validation and QA that ran through Q3, rather than two unrelated problems that happened to land in the same quarter by coincidence. The register caught the pattern inside the quarter, when it could still be corrected with temporary coverage, instead of at the next periodic review cycle, months later, when the overdue count could have doubled and the approval backlog could have started delaying actual releases rather than just looking untidy on a chart. Fed to Q3 management review with the staffing gap flagged as the root issue, and a note that the fix (temporary coverage plus a second approver) is deliberately short-term, because the real decision, whether the team is sized for its workload, belongs to the resourcing conversation, not to this register.
Common inspection findings this register prevents
- A validation backlog that grows quietly for several quarters because no one is tracking the trend, only whether each individual project eventually finishes.
- Periodic reviews overdue on exactly the systems that make batch release decisions, discovered only when an inspector asks for the schedule.
- Open validation deviations with no stated risk position or target date, carried forward period after period with no visible aging.
- A protocol approval bottleneck at one role that is never surfaced because each individual delay looks reasonable in isolation.
- Two unrelated-looking metric breaches that actually share one root cause, such as a staffing gap, never connected because each metric is reviewed on its own.
How to adapt this register
- Set your document number, owner, and review cadence in the header.
- Set your own thresholds in section 2 from your historical baseline; a threshold copied from another site’s program without checking your own volume and risk profile is not defensible.
- Add or drop columns to match the metrics your validation master plan and quality manual actually commit to tracking.
- Point the cross-reference to your real management review procedure.
- Decide whether this register is maintained manually or generated from your validation inventory and change control system’s own reporting; either is acceptable if the source data is reliable and the register is reviewed and signed every period.
- Confirm every regulation in the references against the current published version before issue.